Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Behrens

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Oncology|August 26, 2011
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyPhilip E Castle, Mark H Stoler, Thomas C Wright, et al.
International Journal of Cancer|July 19, 2012
Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesionsJack Cuzick, J Thomas Cox, Guili Zhang, et al.
Gynecologic Oncology|January 18, 2017
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trialThomas C Wright, Catherine M Behrens, James Ranger-Moore, et al.
American Journal of Clinical Pathology|January 21, 2012
The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV studyMark H Stoler, Thomas C Wright, Abha Sharma, et al.
International Journal of Cancer|February 7, 2016
Evaluating HPV-negative CIN2+ in the ATHENA trialKarl Ulrich Petry, J Thomas Cox, Kristin Johnson, et al.
JAMA Network Open|May 19, 2025
Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical TrialMegan B Fitzpatrick, Catherine M Behrens, Karl Hibler, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Oncology|August 26, 2011
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyPhilip E Castle, Mark H Stoler, Thomas C Wright, et al.
International Journal of Cancer|July 19, 2012
Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesionsJack Cuzick, J Thomas Cox, Guili Zhang, et al.
Gynecologic Oncology|January 18, 2017
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trialThomas C Wright, Catherine M Behrens, James Ranger-Moore, et al.
American Journal of Clinical Pathology|January 21, 2012
The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV studyMark H Stoler, Thomas C Wright, Abha Sharma, et al.
International Journal of Cancer|February 7, 2016
Evaluating HPV-negative CIN2+ in the ATHENA trialKarl Ulrich Petry, J Thomas Cox, Kristin Johnson, et al.
JAMA Network Open|May 19, 2025
Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical TrialMegan B Fitzpatrick, Catherine M Behrens, Karl Hibler, et al.
Pageof 2